BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27461629)

  • 1. Critical appraisal of stromal CD10 staining in fibroepithelial lesions of breast with a special emphasis on expression patterns and correlation with WHO grading.
    Puri V; Jain M; Mahajan G; Pujani M
    J Cancer Res Ther; 2016; 12(2):667-70. PubMed ID: 27461629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
    Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
    J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of stromal CD10 expression in benign, borderline, and malignant phyllodes tumors among Egyptian female patients.
    Ibrahim WS
    Indian J Pathol Microbiol; 2011; 54(4):741-4. PubMed ID: 22234101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
    Tsai WC; Jin JS; Yu JC; Sheu LF
    Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroepithelial lesions; The WHO spectrum.
    Krings G; Bean GR; Chen YY
    Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phyllodes tumor of the breast: role of CD10 in predicting metastasis.
    Al-Masri M; Darwazeh G; Sawalhi S; Mughrabi A; Sughayer M; Al-Shatti M
    Ann Surg Oncol; 2012 Apr; 19(4):1181-4. PubMed ID: 22006372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CD10 Immunoexpression in Grading Phyllodes Tumour of the Breast.
    Kulkarni MM; Khandeparkar SG; Joshi AR; Kothikar V; Nasare A; Patil S; Niraspatil S; Dhande B
    J Clin Diagn Res; 2017 Jan; 11(1):EC14-EC16. PubMed ID: 28273972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
    Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
    Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic stromal histomorphology in fibroepithelial breast lesions: a fresh perspective.
    Aiyer HM; Jain M; Thomas S; Logani KB
    Indian J Pathol Microbiol; 2000 Jan; 43(1):5-12. PubMed ID: 12583412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD10+ stromal cells in fibroadenomas and phyllodes tumors of the breast.
    Zamecnik M; Kinkor Z; Chlumska A
    Virchows Arch; 2006 Jun; 448(6):871-2. PubMed ID: 16550395
    [No Abstract]   [Full Text] [Related]  

  • 11. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem.
    Krishnamurthy S; Ashfaq R; Shin HJ; Sneige N
    Cancer; 2000 Dec; 90(6):342-9. PubMed ID: 11156517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor, CD10, and factor 8 in phyllodes tumor: A 5-year study of 38 cases.
    Chaudhary D; Singh M; Kushwaha P; Agarwal R; Singh V; Mandal S; Khurana N; Mishra A
    J Cancer Res Ther; 2020; 16(6):1408-1411. PubMed ID: 33342805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10-a new prognostic stromal marker in breast carcinoma, its utility, limitations and role in breast cancer pathogenesis.
    Jana SH; Jha BM; Patel C; Jana D; Agarwal A
    Indian J Pathol Microbiol; 2014; 57(4):530-6. PubMed ID: 25308002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.
    Resetkova E; Khazai L; Albarracin CT; Arribas E
    Breast J; 2010; 16(6):573-80. PubMed ID: 21070433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision?
    Jacobs TW; Chen YY; Guinee DG; Holden JA; Cha I; Bauermeister DE; Hashimoto B; Wolverton D; Hartzog G
    Am J Clin Pathol; 2005 Sep; 124(3):342-54. PubMed ID: 16191502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit of fibroepithelial tumors of the breast in a Nigerian tertiary institution.
    Daramola AO; Oguntunde OA; Awolola NA
    Niger J Clin Pract; 2016; 19(5):645-8. PubMed ID: 27538554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of fibroepithelial tumours of the breast.
    Badhe BA; Iyengar KR; Alva N
    Indian J Cancer; 2002; 39(3):91-6. PubMed ID: 12928563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the Diagnosis of Phyllodes Tumors and Fibroadenomas Before and After Release of WHO Classification Standards.
    Chang J; Denham L; Dong EK; Malek K; Lum SS
    Ann Surg Oncol; 2018 Oct; 25(10):3088-3095. PubMed ID: 29987607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
    Feakins RM; Wells CA; Young KA; Sheaff MT
    Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.
    Bellezza G; Prosperi E; Del Sordo R; Colella R; Rulli A; Sidoni A
    Int J Surg Pathol; 2016 Feb; 24(1):37-42. PubMed ID: 26353850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.